150 related articles for article (PubMed ID: 3332163)
1. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
Delwel R; Bot F; Knapp W; Löwenberg B
Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
Delwel R; van Gurp R; Bot F; Touw I; Löwenberg B
Leukemia; 1988 Dec; 2(12):814-9. PubMed ID: 3199876
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
6. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
7. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
8. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
9. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K
Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
Ball ED; Howell AL
J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649
[TBL] [Abstract][Full Text] [Related]
12. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
[TBL] [Abstract][Full Text] [Related]
13. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies.
Ball ED
Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
Howell AL; Fogg-Leach M; Davis BH; Ball ED
Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
Mills LE; Ball ED; Howell AL; Cornwell GG; Thompson L; Spruce W; Miller WE; McMillan R
Prog Clin Biol Res; 1990; 333():165-70. PubMed ID: 2308980
[No Abstract] [Full Text] [Related]
16. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
[TBL] [Abstract][Full Text] [Related]
17. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
19. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
20. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W
Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
